BioAlliance Pharma's Series C Round

BioAlliance Pharma raised a round of funding on August 30, 2004.

BioAlliance Pharma develops and markets products in France, especially in the fields of opportunistic infections and chemotherapy complications. In areas where medical needs are not met, BioAlliance P…

Articles about BioAlliance Pharma's Series C Round: